MASSACHUSETTS GENERAL HOSPITAL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
A Study of Sertraline to Prevent PTSD
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT00182078
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2010-07-23
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00181675
- Locations
- 🇺🇸
Massachusetts General Hospital, Cambridge, Massachusetts, United States
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 43
- Registration Number
- NCT00158262
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT00157573
Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 95
- Registration Number
- NCT00157547
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-01-03
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 83
- Registration Number
- NCT00157560
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
- Conditions
- Interventions
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2017-12-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT00149799
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Rhode Island Hospital, Providence, Rhode Island, United States
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00147212
- Locations
- 🇺🇸
Masachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2018-04-25
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT00142480
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT00142467
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States